As of 2026-04-05, the Fair Value of Ovid Therapeutics Inc (OVID) is -3.34 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 2.20 USD, the upside of Ovid Therapeutics Inc is -252.01%.
With the market price of 2.20 USD and our fair value calculation, Ovid Therapeutics Inc (OVID) is not a good investment. Investing in OVID stocks now will result in a potential loss of 252.01%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 5Y Avg | |
| Net income | 122.80 | -54.20 | -52.34 | -26.43 | -17.41 | -5.52 |
| YoY growth | 251.60% | -144.14% | 3.43% | 49.50% | 34.12% | 38.90% |
| Market Cap (mil) | 286.40 |
| P/E | |
| Forward P/E |
| EPS | -0.13 |
| Avg earnings growth rate | 38.90% |
| TTM earnings | -17.41 |